...Pot stock Zelira (ASX:ZLD) may have only had 23 people in its recent insomnia study, but it was a cross-over study meaning the participants are switched throughout to all treatments.CEO Richard Hopkins says in effect this means they had 46 subjects and therefore enough to deliver statistically significant results.Good trials, whether they are destined to succeed or fail, will attract star investigators and key opinion leaders...
ZLD Price at posting:
5.3¢ Sentiment: Buy Disclosure: Held
